Search research articles
Contact Us
Filters
Showing results (141-150 of 557) with videos related to
Page
of 56
Sort By:
Best Practice & Research. Clinical Haematology
|
July 23, 2025
Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface
Thomas R Spitzer, Hillard M Lazarus, Robert Peter Gale
Cancer Cell International
|
August 9, 2025
Predicting survival of persons with newly-diagnosed multiple myeloma
Limei Zhang, Yun Wang, Robert Peter Gale, et al.
Best Practice & Research. Clinical Haematology
|
December 13, 2023
The role of randomized controlled trials, registries, observational databases in evaluating new interventions
Robert Peter Gale, Mei-Jie Zhang, Hillard M Lazarus
Blood Reviews
|
March 11, 2026
Ph-chromosome-negative myeloproliferative neoplasms: clonal dynamics are the name of the game
Mohammadamin Noorafrooz, Ramin Noorafrooz, Giovanni Barosi, et al.
Bone Marrow Transplantation
|
November 12, 2024
Strategies following failure of CAR-T-cell therapy in non-Hodgkin lymphoma
Xiaotian Zhang, Kailin Xu, Robert Peter Gale, et al.
Bone Marrow Transplantation
|
November 29, 2020
New cancer therapies. Are haematopoietic cell transplants a dead duck?
Robert Peter Gale, Gordon L Phillips, Hillard M Lazarus
Journal of Cancer Research and Clinical Oncology
|
September 13, 2017
Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia
Qian Jiang, Haibo Wang, Lu Yu, et al.
Leukemia
|
June 8, 2018
New drugs in AML: uses and abuses
Elihu H Estey, Robert Peter Gale, Mikkael A Sekeres
Bone Marrow Transplantation
|
May 19, 2019
Direct adjusted survival and cumulative incidence curves for observational studies
Zhen-Huan Hu, Robert Peter Gale, Mei-Jie Zhang
Best Practice & Research. Clinical Haematology
|
July 23, 2025
CAR-NK cells for haematological cancers
Mohammadamin Noorafrooz, Robert Peter Gale, Ramin Noorafrooz, et al.
Page
of 56
Search research articles
Search
Showing results (141-150 of 557) with videos related to
Sort By:
Page
of 56
Best Practice & Research. Clinical Haematology
|
July 23, 2025
Cytokines in hematology, hematopoietic cell transplantation and immune effector cell therapy: Preface
Thomas R Spitzer, Hillard M Lazarus, Robert Peter Gale
Cancer Cell International
|
August 9, 2025
Predicting survival of persons with newly-diagnosed multiple myeloma
Limei Zhang, Yun Wang, Robert Peter Gale, et al.
Best Practice & Research. Clinical Haematology
|
December 13, 2023
The role of randomized controlled trials, registries, observational databases in evaluating new interventions
Robert Peter Gale, Mei-Jie Zhang, Hillard M Lazarus
Blood Reviews
|
March 11, 2026
Ph-chromosome-negative myeloproliferative neoplasms: clonal dynamics are the name of the game
Mohammadamin Noorafrooz, Ramin Noorafrooz, Giovanni Barosi, et al.
Bone Marrow Transplantation
|
November 12, 2024
Strategies following failure of CAR-T-cell therapy in non-Hodgkin lymphoma
Xiaotian Zhang, Kailin Xu, Robert Peter Gale, et al.
Bone Marrow Transplantation
|
November 29, 2020
New cancer therapies. Are haematopoietic cell transplants a dead duck?
Robert Peter Gale, Gordon L Phillips, Hillard M Lazarus
Journal of Cancer Research and Clinical Oncology
|
September 13, 2017
Higher out-of-pocket expenses for tyrosine kinase-inhibitor therapy is associated with worse health-related quality-of-life in persons with chronic myeloid leukemia
Qian Jiang, Haibo Wang, Lu Yu, et al.
Leukemia
|
June 8, 2018
New drugs in AML: uses and abuses
Elihu H Estey, Robert Peter Gale, Mikkael A Sekeres
Bone Marrow Transplantation
|
May 19, 2019
Direct adjusted survival and cumulative incidence curves for observational studies
Zhen-Huan Hu, Robert Peter Gale, Mei-Jie Zhang
Best Practice & Research. Clinical Haematology
|
July 23, 2025
CAR-NK cells for haematological cancers
Mohammadamin Noorafrooz, Robert Peter Gale, Ramin Noorafrooz, et al.
Page
of 56